Abstract
In the present study, a detailed biocompatibility testing of a novel class of hybrid nanostructure based on hyperbranched polyglycerol and β-cyclodextrin is conducted. This highly water soluble nanostructure with size of less than 10 nm, polydispersity of less than 1.3, chemical tenability and highly branched architecture with the control over branching structure could be potentially used as a carrier in drug delivery systems. To this end, extensive studies in vitro and in vivo conditions have to be demonstrated. The in vitro studies include in vitro cytotoxicity tests; MTT and Neutral Red assay as an indicator of mitochondrial and lysosomal function, and blood biocompatibility tests such as effects on coagulation cascade, and complement activation. The results show that these hybrid nanostructures, which can be prepared in a simple reaction, are considerably biocompatible. The in vivo studies showed that the hybrid nanostructure is well tolerated by rats even in high doses of 10 mg ml−1. After autopsy, the normal structure of liver tissue was observed; which divulges high biocompatibility and their potential applications as drug delivery and nanomedicine.
Graphical Abstract
Similar content being viewed by others
References
Yan D, Gao C, Frey H. Hyperbranched Polymers. Synthesis, Properties, and Applications. Hoboken: John Wiley & Sons; 2011.
Gao C, Yan D. Hyperbranched polymers: from synthesis to applications. Prog Polym Sci. 2004;29:183–275.
Frey H. Dendritic polymers: universal glue for cells. Nat Mat. 2012;11:359–60.
Jin H, Huang W, Zhu X, Zhou Y, Yana D. Biocompatible or biodegradable hyperbranched polymers: from self-assembly to cytomimetic applications. Chem Soc Rev. 2012;41:5986–97.
Wu Y, Jiao F, Han S, Fan T, Liu Y, Li W, et al. Construction of amphiphilic copolymer nanoparticles based on hyperbranched poly (Amine-Ester) and 1,2-Dipalmitoyl-Sn-Glycero-3-Phosphoethanolamine as drug carriers for cancer therapy. Nanomed Nanotech Biol Med. 2011;7:945–54.
Naeini AT, Adeli M, Vossoughi M. Poly(citric acid)-block-poly(ethylene glycol) copolymers—new biocompatible hybrid materials for nanomedicine. Nanomed Nanotech Biol Med. 2010;6:556–62.
Frey H, Haag R. Dendritic polyglycerol: a new versatile biocompatible material. Rev Mol Biotechnol. 2002;90:257–67.
Zarrabi A, Adeli M, Vossoughi M, Shokrgozar MA. Design and synthesis of novel polyglycerol hybrid nanomaterials for potential applications in drug delivery systems. Macromol Biosci. 2011;11:383–90.
Calderón M, Warnecke A, Gräser R, Haag R, Kratz F. Development of enzymatically cleavable doxorubicin conjugates with polyglycerol. J Controlled Release. 2008;132:e54–5.
Kizhakkedathu JN, Hester SR, Chapanian R, Lai BFL, Imran ul-haq M. Influence of architecture of high molecular weight linear and branched polyglycerols on their biocompatibility and biodistribution. Biomaterials. 2012;33:9135–47.
Kainthan RK, Hester SR, Levin E, Devine DV, Brooks DE. In vitro biological evaluation of high molecular weight hyperbranched polyglycerols. Biomaterials. 2007;28:4581–90.
Sisson AL, Steinhilber D, Rossow T, Welker P, Licha K, Haag R. Biocompatible functionalized polyglycerol microgels with cell penetrating properties. Angew Chem Int Ed. 2009;48:7540–5.
Saatchi K, Soema P, Gelder N, Misri R, McPhee K, Baker JHE, et al. Hyperbranched polyglycerols as trimodal imaging agents: design, biocompatibility, and tumor uptake. Bioconj Chem. 2012;23:372–81.
Siegers C, Biesalki M, Haag R. Self-assembled monolayers of dendritic polyglycerol derivatives on gold that resist the adsorption of proteins. Chem Eur J. 2004;10:2831–8.
Kainthan RK, Brooks DE. In vivo biological evaluation of high molecular weight hyperbranched polyglycerols. Biomaterials. 2007;28:4779–87.
Zarrabi A, Vossoughi M, Alemzadeh I, Chitsazi MR. Monodispersed polymeric nanoparticles fabrication by electrospray atomization. Int J Polym Mat Polym Biomat. 2012;61:611–26.
Lim HJ, Cho EC, Jongwon S, Do-Hoon K, An EJ, Junoh K. Polymer-associated liposomes as a novel delivery system for cyclodextrin-bound drugs. J Colloid Interface Sci. 2008;320:460–8.
Bertolla C, Rolin S, Evrard B, Pochet L, Masereel B. Synthesis and pharmacological evaluation of a new targeted drug carrier system: β-cyclodextrin coupled to oxytocin. Bioorg Med Chem Lett. 2008;18:1855–8.
Zhang X, Zhang X, Wu Z, Gao X, Cheng C, Wang Z, et al. A hydrotropic b-cyclodextrin grafted hyperbranched polyglycerol co-polymer for hydrophobic drug delivery. Acta Biomater. 2011;7:585–92.
Naahidi S, Jafari M, Edalat F, Raymond K, Khademhosseini A, Chen P. Biocompatibility of engineered nanoparticles for drug delivery. J Control Release. 2013;166:182–94.
Zange R, Li Y, Kissel T. Biocompatibility testing of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to a central poly(ethylene oxide) B block under in vitro conditions using different L929 mouse fibroblasts cell culture models. J Controlled Release. 1998;56:249–58.
Ulreich JB, Chavapilin M. In vitro toxicity testing: a quantitative microassay. In: Brown SA, editor. Cell Culture Test Methods. Philadelphia: ASTM; 1983. p. 102–13.
Ozdemir KG, Yilmaz H, Yilmaz S. In vitro evaluation of cytotoxicity of soft lining materials on L929 cells by MTT assay. J Biomed Mater Res Part B. 2009;90B:82–6.
Adeli M, Kalantari M, Sadeghi E, Mahmoudi M. Synthesis of new hybrid nanomaterials: promising systems for cancer therapy. Nanomed Nanotech Biol Med. 2011;7:806–17.
Dobrovolskaia MA, Patri AK, Zheng J, Clogstona JD, Ayub N, Aggarwal P, et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomed Nanotech Biol Med. 2009;5:106–17.
Biological evaluation of medical devices. Part 5, Tests for in vitro cytotoxicity, BS EN ISO 10993-5:2009, 2009.
Gorbet MB, Sefton MV. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials. 2004;25:5681–703.
Kainthan RK, Gnanamani M, Ganguli M, Ghosh T, Brooks DE, Maiti S, et al. Blood compatibility of novel water soluble hyperbranched polyglycerol-based multivalent cationic polymers and their interaction with DNA. Biomaterials. 2006;27:5377–90.
Moghimi SM, Davis SS. Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection. Crit Rev Ther Drug Carrier Syst. 1994;11:31–59.
Stolnik S, Illum L, Davis SS. Long circulating micro particulate drug carriers. Adv Drug Deliv Rev. 1995;16:195–214.
Johnson RJ. The Complement System. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, editors. Biomaterials Science; An Introduction to Materials in Medicine. 2nd ed. California: Elsevier Academic Press; 2004. p. 318–27.
Payne MS, Horbett TA. Complement activation by hydroxyethylmethacrylate-ethylmethacrylate copolymers. J Biomed Mater Res Part A. 1987;21:843–59.
Gutierrez A, Alvestrand A, Bergström J, Beving H, Lantz B, Henderson LW. Biocompatibility of hemodialysis membranes: a study in healthy subjects. Blood Purif. 1994;12:95–105.
Lamba NMK, Courtney JM, Gaylor JD, Lowe GDO. In vitro investigation of the blood response to medical grade PVC and the effect of heparin on the blood response. Biomaterials. 2000;21:89–96.
Kainthan RK, Janzen J, Levin E, Devine DV, Brooks DE. Biocompatibility testing of branched and linear polyglycidol. Biomacromolecules. 2006;7:703–9.
Janatova J. Activation and control of complement, inflammation, and infection associated with the use of biomedical polymers. ASAIO J. 2000;46:S53–62.
Beillatt J, Dorson WJ. Hemocompatibility studies: quantification of serum complement activation by polymeric membranes and materials. ASAIO J. 1984;7:57–63.
Yu J, Lamba NMK, Courtney JM, Whateley TL, Gaylor JD, Lowe GDO, et al. Polymeric biomaterials: influence of phosphorylcholine polar groups on protein adsorption and complement activation. Int J Artif Organs. 1994;17:499–504.
Acknowledgments
We thank the funding by Iran Nanotechnology Initiative Council (INIC), Dr. Masoud Davanlou, MD, Danesh Pathobiology Laboratory for blood compatibility tests, and Ms. Somayeh Nazerian for her kind contribution in PT and APTT tests.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zarrabi, A., Shokrgozar, M.A., Vossoughi, M. et al. In vitro biocompatibility evaluations of hyperbranched polyglycerol hybrid nanostructure as a candidate for nanomedicine applications. J Mater Sci: Mater Med 25, 499–506 (2014). https://doi.org/10.1007/s10856-013-5094-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-013-5094-z